CHRISTINA BLAESING: Open Payments
NPI 1316135486 · BALLWIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 59 payments from 16 companies in 2025. Trend: 2023 $333 · 2024 $482 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 27 | $208 |
| ABBVIE INC. | 4 | $78 |
| Lilly USA, LLC | 4 | $73 |
| Sumitomo Pharma America, Inc. | 4 | $70 |
| Novo Nordisk Inc | 4 | $69 |
| Novartis Pharmaceuticals Corporation | 2 | $59 |
| TMS NeuroHealth Centers Inc. | 1 | $43 |
| Exact Sciences Corporation | 2 | $35 |
| Abbott Laboratories | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
Products named: NURTEC ODT, ELIQUIS, QULIPTA, MOUNJARO, GEMTESA, LEQVIO, Wegovy, TMS NeuroHealth Centers Inc..
Industry payments across MO — which companies pay providers there.
